YUNMAI
21.7.2022 11:53:08 CEST | Business Wire | Press release
The leading wellness equipment brand Yunmai is announcing the #YunmaiAthletes community campaign. Yunmai serves professional players across different sports by supporting them with professional, effective, and portable muscle recovery solutions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220718005331/en/
In April 2021, Yunmai announced its first Global Brand Ambassador, Ansu Fati, the "New No. 10" from FC Barcelona, who inherited the number from Lionel Messi, for its line of massage guns. “Join Yunmai Athletes, enter a new dimension, and achieve your peak athletic performance,” said Ansu Fati. At the young age of 17 years, Fati had already set athletic world records that made him the obvious choice to represent Yunmai on a global stage.
Yunmai‘s products are designed to empower sports enthusiasts and especially professional athletes to fully control their fitness and wellness. For many athletes, Yunmai massage guns have been part of their daily training routine to enhance their performance during competitions. In addition to Ansu Fati, the world’s No. 1 Badminton player Viktor Axelsen, who has won two Olympic medals, favors his Yunmai Massage Gun Pro Basic: “To keep my training session challenging, it's essential to have Yunmai relaxation gadgets at my disposal.”
Three-time Olympic gold medalist Kaillie Humphries also approves of the powerful Yunmai Massage Gun Slim Chic: “Whether I'm warming up before lifting or cooling down after a competition, the Yunmai massage gun helps me recover faster.” Humphries’ hard training and winning moments on the field are enabled by Yunmai’s high-quality percussive therapy devices to improve her pre-workout activation and post-workout muscle recovery.
Yunmai is dedicated to help users “Simplify Your Workout” and unlock the best version of themselves with quick warm-ups, instant recovery, and precise data tracking. “I love how Yunmai lets me take control of recovery in a simple and efficient way,” explained Joey Haywood, the streetball legend from Canada.
Yunmai specializes in technology-driven massage guns, smart scales, and smart jump ropes, which are sold in over 115 countries today. Yunmai’s award-winning products have been featured in a wide range of well-known global media outlets, including CNN, Forbes, Rolling Stone, and the Wall Street Journal.
About Yunmai
The sports and fitness brand Yunmai has been using technology and innovation to enhance workouts since 2014. Yunmai pioneered the manufacturing of smart scales and continues to innovate in the smart health market.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220718005331/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Angel Aligner Unveils Six Innovations for 202711.11.2026 17:23:00 CET | Press release
Angel Elevates the Orthodontic Specialty by Focusing on Complex-Case Solutions Angelalign Technology Inc. (6699.HK) (“Angel”), a global clear aligner leader, has unveiled six new clinical innovations, including SuperElastic (MC-SE)* aligner material, a Deepbite Solution for significantly expanded indications, and the Adapt-MATMsystem for next generation growth guidance for young patients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261110338654/en/ Unveiling Angel's 2027 Innovations. Orthodontists and opinion leaders have long remarked about Angel’s clinical excellence. Orthodontics educator and thought leader Dr. David Sarver said: “In over 4 decades, I’ve never had a parent say I’d be happy if you ensure that my child’s treatment results are average.” Angel is committed to elevating the orthodontic specialty well above the average, especially as more competition and harder referral cases demand outstanding results. Bind
Abu Dhabi Future Health Summit Concludes with Research Partnerships and New Programmes to Advance Prevention and Health Innovation11.11.2026 15:58:00 CET | Press release
Partnerships span drug discovery, clinical research, preventive and reproductive health Launch of an AI Clinician Framework and a Trusted Research Environment for health and genomic data Four whitepapers address genomics, therapeutics, fertility and wearable technologies New programmes support health innovators and entrepreneurs More than 17,300 visitors from 85 countries, with 130 speakers across 45 sessions Held under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive Council, Abu Dhabi Future Health Summit 2026 concluded with agreements and initiatives spanning drug discovery, clinical research, preventive and reproductive health, alongside research and entrepreneurship programmes that will sustain collaboration beyond the Summit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261111545964/en/ The Summit is the annual flagship gath
De' Longhi Group: Record Results for the Quarter, With Revenue Growing by 7.7% and Net Profit Pertaining to the Group Progressing Significantly by 19%11.11.2026 15:58:00 CET | Press release
The Board of Directors of De' Longhi S.p.A. approved the consolidated results1 for the nine months of 2026. In the nine months the Group achieved: revenues for € 2,621.3 million, up by 6.5% with respect to 2025 (+7.7% at constant currency); an adjusted2 Ebitda of € 455.2 million, equal to 17.4% on revenues (vs. 15.8% with respect to last year); a net income pertaining to the Group equal to € 225.8 million (+20.4% with respect to last year); a positive net financial position equal to € 606.0 million. CEO Fabio de' Longhi commented: “The Group delivered its thirteenth consecutive quarter of organic revenue growth, underscoring our proven ability to capitalize on industry opportunities and respond promptly to market evolution, while ensuring consistent performance across both divisions. The professional business recorded a strong acceleration, spanning all geographies and brands, with revenues growth exceeding 35% for both the quarter and the nine-month period, this against an already par
Starr Chile Assigned A Rating from AM Best11.11.2026 14:30:00 CET | Press release
Starr, a global insurance and investment organization, today announced that the global credit rating agency AM Best has assigned Starr International Seguros Generales S.A. (Starr Chile) a Financial Strength Rating of A (Excellent) and a Long-Term Issuer Credit Rating of a+ (Excellent). The outlook for both credit ratings is positive. The rating reflects Starr’s strong balance sheet and Starr Chile’s successful implementation of Starr’s business model. AM Best also cited Starr’s operating performance, a favorable business profile and enterprise risk management as key factors supporting the positive rating. “This strong rating is another important endorsement of Starr’s business model as we continue to build our presence in Latin America,” said Jeff Greenberg, chairman and co-CEO of Starr. “It reflects the financial strength, underwriting discipline and experienced teams that underpin our business around the world, reinforcing the confidence brokers and clients can place in Starr.” Starr
Epinal, Inc. Emerges from Stealth with First-of-Its-Kind Breakthrough Semiconductor Electrochemical Biosensor (SEB) for Detection of Narcotics and Disease Biomarkers in Human Breath in Minutes11.11.2026 14:22:00 CET | Press release
Southern California-Based Company has developed a disruptive biosensor for integration into next-generation screening and diagnostic devices Epinal, Inc., after over six years of under-the-radar development, has officially emerged from stealth mode, introducing a breakthrough Semiconductor Electrochemical Biosensor (SEB) designed to detect narcotics and disease biomarkers directly from human breath in minutes. By combining advanced semiconductors, electrochemical sensing, tailored protein engineering, and artificial intelligence, Epinal has addressed the historical sensitivity, selectivity, scaling, stability, and signal-to-noise limitations that have long bottlenecked biosensors. Epinal’s Semiconductor Electrochemical Biosensor (SEB) will be integrated into the next generation of low cost, disposable, single-use breathalyzer cartridges where the integrity of test results is of utmost importance. In the case of narcotic detection, a rapid, non-invasive, and objective result changes an
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom